FORM OF NON-STATUTORY STOCK OPTION AGREEMENT1Non-Statutory Stock Option Agreement • February 27th, 2020 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Illinois
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionTHIS NON-STATUTORY STOCK OPTION AGREEMENT is entered into and effective as of this _______ day of _________, 20__ (the “Date of Grant”), by and between ANI Pharmaceuticals, Inc., formerly known as BioSante Pharmaceuticals, Inc. (the “Company”) and _________ (the “Optionee”).
FORM OF INCENTIVE STOCK OPTION AGREEMENT1Incentive Stock Option Agreement • February 27th, 2020 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionTHIS INCENTIVE STOCK OPTION AGREEMENT is entered into and effective as of this day of ______, 20___ (“Date of Grant”), by and between ANI Pharmaceuticals, Inc. (the “Company”) and (the “Optionee”).
Confidential materials have been omitted pursuant to Rule 601 under the Securities Act of 1933, as amended. Such information is both not material and would likely cause competitive harm to ANI Pharmaceuticals, Inc. if publically disclosed....Asset Purchase Agreement • February 27th, 2020 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • New York
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionThis ASSET PURCHASE AGREEMENT, dated as of January 8, 2020 (this “Agreement”), is by and between Amerigen Pharmaceuticals Ltd., a Cayman Islands exempt company (“Seller”) and ANI Pharmaceuticals, Inc., a Delaware corporation (“Purchaser”). Capitalized terms are defined on the pages of this Agreement set forth opposite the capitalized terms listed in the Index of Defined Terms.
RESTRICTED STOCK GRANT AGREEMENTRestricted Stock Grant Agreement • February 27th, 2020 • Ani Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
Contract Type FiledFebruary 27th, 2020 Company Industry JurisdictionThis Restricted Stock Grant Agreement (this “Agreement”) is entered into as of [●], by and between ANI Pharmaceuticals, Inc., a Delaware corporation (the “Company”) and [●] (“Recipient”). The parties hereby agree as follows: